Fieldpoint Private Advisors’s AbbVie ABBV Stock Holding History

Fieldpoint Private Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-17,540	Closed	-$1.07M	–	65
2016 Q1	$1.07M	Hold	17,540	–	–	0.76%	46
2015 Q4	$1.04M	Sell	17,540 -650	-4%	-$37.4K	0.73%	48
2015 Q3	$990K	Hold	18,190	–	–	0.68%	50
2015 Q2	$1.22M	Sell	18,190 -800	-4%	-$52.2K	0.76%	47
2015 Q1	$1.11M	Hold	18,990	–	–	0.68%	50
2014 Q4	$1.24M	Sell	18,990 -62,845	-77%	-$3.96M	0.8%	46
2014 Q3	$4.73M	Sell	81,835 -12,860	-14%	-$714K	3.06%	3
2014 Q2	$5.34M	Sell	94,695 -6,155	-6%	-$323K	3.23%	1
2014 Q1	$5.18M	Sell	100,850 -8,135	-7%	-$411K	3.08%	4
2013 Q4	$5.75M	Sell	108,985 -235	-0.2%	-$11.6K	3.3%	2
2013 Q3	$4.88M	Buy	109,220 +17,130	+19%	+$759K	2.99%	3
2013 Q2	$3.81M	Buy	+92,090	New	+$4.03M	2.34%	13

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Fieldpoint Private Advisors's ABBV Position: Q2 2016 in Review

Fieldpoint Private Advisors sold out of AbbVie (ABBV) in Q2 2016, closing a stake of 17,540 shares — an estimated $1.07M sold.

Fieldpoint Private Advisors first reported a position in ABBV in Q2 2013 and held it in 12 quarters. The position peaked at $5.75M in Q4 2013. 1,636 funds tracked by Wall St. Rank hold ABBV as of Q2 2016.

Fieldpoint Private Advisors reported no remaining AbbVie position as of Q2 2016 after selling out during the quarter.
Fieldpoint Private Advisors sold 17,540 AbbVie shares in Q2 2016, an estimated $1.07M.
Fieldpoint Private Advisors first reported a position in AbbVie in Q2 2013 and held it in 12 quarters.
Fieldpoint Private Advisors's AbbVie position peaked at $5.75M in Q4 2013.
1,636 funds tracked by Wall St. Rank held AbbVie as of Q2 2016.

Based on Fieldpoint Private Advisors's 13F filing for Q2 2016, filed 5 Aug 2016.